Corporate Finance

SDEV reported a massive Q1 profit, but the real story is its unique strategy as a public DeFi holding company and the complex accounting behind the numbers.

A new report warns a sharp drop in telecom investment threatens Canada's economy, pitting the need for future-proof networks against the push for lower prices.

With new funding from top investors, Alacriti is set to accelerate its push into AI, fraud prevention, and programmable money for financial institutions.

With new CMO Anisha Raghavan, the science-heavy supplement brand plans to translate its complex clinical research into mainstream consumer success.

Fintech lender Octane expands its partnership with investment giant Nuveen, bolstering its funding to meet soaring demand in powersports and RV financing.

Riding a wave of strong earnings, EuroDry invests $74M in eco-friendly vessels, betting on a green future for the recovering drybulk market.

As Drake's triple-album shatters records, a new financing deal for his OVO brand reveals how investors are turning cultural influence into a new asset class.

A novel drug is in clinical trials for depression, moving beyond neurotransmitters to target the brain's fundamental energy production and repair mechanisms.

AI finance firm Terzo hires a partnership expert to expand its platform that turns enterprise contracts into billions of dollars in recovered profit.

A new clinical trial is testing a device that uses electricity to deliver chemo directly into tumors, a strategy that could revolutionize treatment.

UC Irvine and Konnect partner on a new certification to equip senior HR leaders with the strategic skills needed to navigate the AI revolution.

Mars is transforming its historic Slough chocolate factory with AI and robotics, signaling a major vote of confidence in the UK's manufacturing future.

Profitable and capital-efficient, the HR platform is using its Series B to scale its integrated payroll and finance solution in the US and Europe.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

Hormel Foods declared its 392nd dividend, but a high payout ratio and lagging stock have investors weighing its legendary reliability against current risks.

As graphene leader NanoXplore appoints CEO Rocco Marinaccio to its board, the move signals a push for faster growth but raises timeless governance questions.

Activist investor BIMIZCI launches a proxy fight, citing a CEO's fraud judgment and 'flip phone' era technology in a battle for Medallion's future.

New projects leverage AI, gene therapy advances, and diverse workforce initiatives to bolster America's manufacturing and secure its talent pipeline.

EcoShield Pest Solutions combines a nationwide push-up challenge with donations to support Wounded Warrior Project, fostering a unique corporate culture.

As marketers demand smarter analytics, Upwave hires industry veteran John Bulgrin as CRO to accelerate its AI-powered brand outcomes measurement platform.